Sieradzan KA - Search Results

1

Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM. Sieradzan KA, et al. Exp Neurol. 1999 Mar;156(1):92-9. doi: 10.1006/exnr.1998.7005. Exp Neurol. 1999. PMID: 10192780

2

The selective vulnerability of nerve cells in Huntington's disease.

Sieradzan KA, Mann DM. Sieradzan KA, et al. Neuropathol Appl Neurobiol. 2001 Feb;27(1):1-21. doi: 10.1046/j.0305-1846.2001.00299.x. Neuropathol Appl Neurobiol. 2001. PMID: 11298997 Review.

3

On the pathological progression of Huntington's disease.

Sieradzan KA, Mann DM. Sieradzan KA, et al. Ann Neurol. 1998 Jul;44(1):148-9. doi: 10.1002/ana.410440127. Ann Neurol. 1998. PMID: 9667607 No abstract available.

4

Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease.

Sieradzan K, Mann DM, Dodge A. Sieradzan K, et al. Neurosci Lett. 1997 Mar 28;225(1):45-8. doi: 10.1016/s0304-3940(97)00182-1. Neurosci Lett. 1997. PMID: 9143014 Clinical Trial.

5

Clinical manifestations of intermediate allele carriers in Huntington disease.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network. Cubo E, et al. Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8. Neurology. 2016. PMID: 27402890

6

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators; Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124

7

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network. McNulty P, et al. J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263. J Huntingtons Dis. 2018. PMID: 30103338

8

Meaningful and Measurable Health Domains in Huntington's Disease: Large-Scale Validation of the Huntington's Disease Health-Related Quality of Life Questionnaire Across Severity Stages.

Ho AK, Horton MC, Landwehrmeyer GB, Burgunder JM, Tennant A; European Huntington’s Disease Network. Ho AK, et al. Value Health. 2019 Jun;22(6):712-720. doi: 10.1016/j.jval.2019.01.016. Value Health. 2019. PMID: 31198189 Free article.

9

Observations on the survival of grafted embryonic motoneurons in the spinal cord of developing rats.

Sieradzan K, Vrbová G. Sieradzan K, et al. Exp Neurol. 1993 Aug;122(2):223-31. doi: 10.1006/exnr.1993.1122. Exp Neurol. 1993. PMID: 8405260

10

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.

Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM. Sieradzan KA, et al. Neurology. 2001 Dec 11;57(11):2108-11. doi: 10.1212/wnl.57.11.2108. Neurology. 2001. PMID: 11739835 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters